Day: October 20, 2025

LOS ANGELES, Oct. 20, 2025 (GLOBE NEWSWIRE) — Turn Therapeutics (Nasdaq: TTRX) today announced the launch of a broad communications initiative, featuring a recurring webinar series for shareholders and a forthcoming Founder Blog authored by patient-turned-founder and CEO, Bradley Burnam. “It is an uncommon step to maintain constant engagement with shareholders, partners, and the broader healthcare community,” said Bradley Burnam, Founder and CEO of Turn Therapeutics. “But this company was built by a deeply engaged community, and we intend to continue that conversation as we grow.” The Founder Blog will publicly share ongoing company updates, research insights, and perspectives on Turn’s growth and innovation. Further details about the blog will be announced later this week. The webinar series will provide live discussion covering...

IRVING, Texas, Oct. 20, 2025 (GLOBE NEWSWIRE) — XBP Global Holdings, Inc. (“XBP Global” or “the Company”) (NASDAQ: XBP), a workflow automation leader that leverages decades of industry experience, global footprint and agentic AI to rethink business process automation and digital transformation, has partnered with the New York City Department of Finance to deliver advanced payment processing solutions for parking violation tickets. The department selected XBP Global through a competitive bidding process to augment its payment processing capabilities with XBP Global’s Lockbox Services. The Company’s platform will be utilized to streamline financial transactions for parking violation tickets, thereby enabling the department to reduce cycle time and provide faster and more user-friendly payment experiences. This strategic partnership...

Contributing to Mega-Constellation satellite build-out ROCHESTER, NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) — Syntec Optics Holdings, Inc. (Nasdaq: OPTX) (“Syntec Optics” or the “Company”), a leading provider of technology products to defense, biomedical, communications, and consumer industry leaders, today celebrated another production milestone. The Company has manufactured over 17,000 satellite optics to support thousands of low-Earth-orbit satellite launches. These optics enable satellites to create a laser mesh network, allowing traffic to be routed in space rather than on the ground and delivering data reliably and more quickly. Syntec is utilizing decades of experience in the advanced manufacturing of extremely high-tolerance optics. “Backwards integration into making blanks for final optics is critical to achieve super...

Pat Geraghty Joins EXL’s Board of DirectorsEXL announces the appointment of Pat Geraghty to its Board of Directors, bringing decades of strategic leadership experience to guide the company’s continued growth and innovation in data and AI.NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) — EXL [NASDAQ: EXLS], a global data and AI company, announced that Patrick “Pat” Geraghty, a seasoned chief executive with a strong record of innovation across the healthcare industry, has been appointed to EXL’s Board of Directors as an independent director effective October 20, 2025. Geraghty will be a member of the board’s audit and nominating and governance committees. Chairman and Chief Executive Officer Rohit Kapoor said, “We are delighted to welcome Pat to the board. His years of experience leading large healthcare payer organizations...

Presentations Detail Ongoing Vafseo® (Vadadustat) Real-World Studies and Explore Insights Regarding Clinical Benefits and Dosing of Vafseo CAMBRIDGE, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) — Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that it will present data at the American Society of Nephrology Kidney Week 2025 (ASN Kidney Week), which will take place in Houston, TX from November 5-9, 2025. ASN Kidney Week attendees can also visit Akebia at Booth #903 in the Exhibit Hall. Dr. Glenn M. Chertow of Stanford University will present the results of a win odds analysis of all-cause mortality and hospitalization from the INNO2VATE trials, part of the global Phase 3 clinical development programs for vadadustat. In the...

Investor event to provide update on pivotal Phase 3 study of IMNN-001 to be held in New York City on November 10, 2025 Program will feature presentations from ovarian cancer thought leaders, Phase 3 study investigators, oncology and statistical experts LAWRENCEVILLE, N.J., Oct. 20, 2025 (GLOBE NEWSWIRE) — IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that it will host an R&D Day for investors at the Harvard Club (35 West 44th Street) in New York City on November 10, 2025, beginning at 8:00 a.m. ET. The investor event will feature ovarian cancer thought leaders, principal investigators from the Company’s Phase 3 OVATION 3 Study and Phase 2 minimal residual disease (MRD) clinical trial, conducted in partnership with Break Through Cancer Foundation,...

VANCOUVER, British Columbia, Oct. 20, 2025 (GLOBE NEWSWIRE) — HydroGraph Inc. (CSE: HG) (OTCQB: HGRAF) (“HydroGraph”), a leading producer of ultra-pure graphene, is pleased to announce that President & CEO Kjirstin Breure will present at the Emerging Growth Conference on Thursday, October 23, 2025, at 11:25 am Eastern Time. Ms. Breure will provide an overview presentation and may subsequently open the floor for questions. Questions may be submitted in advance to Questions@EmergingGrowth.com. Investors can register in advance to attend the conference and receive any updates at: https://goto.webcasts.com/starthere.jsp?ei=1717092&tp_key=1ddfafa563&sti=hgraf If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available on EmergingGrowth.com and on the Investors...

Novel combination including eftilagimod alfa (efti) in neoadjuvant setting drives 51.5% tumour hyalinization/fibrosis in patients with soft tissue sarcoma (p

WILMINGTON, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) — Liberty Defense Holdings Ltd. (“Liberty” or the “Company”) (TSXV: SCAN, OTCQB: LDDFF, FRANKFURT: FSE:E30), – a leading technology provider of AI-based next generation detection solutions for concealed weapons and threats, is pleased to announce that its HEXWAVE system was selected by The Jackson County Detention Center in Missouri to screen staff and visitors who enter the facility. The order was received with our distribution partner, Linev Systems U.S. who received the contract from the County. The selection of Liberty Defense’s HEXWAVE technology reaffirms Jackson County’s commitment to securing their facilities with a modern-day security approach, ensuring minimized entry wait times and enabling the most secure and safe access for everyone entering the facilities. The Jackson...